カテゴリー： 世界, 部品/材料, LP Information

世界のMRSA薬剤市場予測 2023年-2029年

【英語タイトル】Global MRSA Drugs Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC00912）・商品コード：LP23DC00912
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：108
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のMRSA薬剤市場」は、過去の販売実績から2022年の世界のMRSA薬剤の総販売量を検討し、2023年から2029年の予測されるMRSA薬剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のMRSA薬剤の市場規模を掲載し、XXX百万米ドル規模の世界のMRSA薬剤市場の詳細な分析を提供します。本インサイトレポートは、世界のMRSA薬剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のMRSA薬剤市場における各社の独自のポジションをより深く理解するために、MRSA薬剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のMRSA薬剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。MRSA薬剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。MRSA薬剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。MRSA薬剤のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

MRSA薬剤の世界主要メーカーとしては、Allergan、 Merck、 Pfizer、 Theravance Biopharma、 Absynth Biologics、 Cumberland Pharmaceuticals、 AstraZeneca、 Basilea Pharmaceuticals、 Baxter、 Melinta Therapeuticsなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のMRSA薬剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではMRSA薬剤市場をセグメンテーションし、種類別 (経口、非経口)、用途別 (病院薬局、小売薬局、電子薬局)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：経口、非経口

・用途別区分：病院薬局、小売薬局、電子薬局

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のMRSA薬剤市場の10年間の市場状況・展望は？
・世界および地域別に見たMRSA薬剤市場成長の要因は何か？
・MRSA薬剤の市場機会はエンドマーケットの規模によってどのように変化するのか？
・MRSA薬剤のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：MRSA薬剤の年間販売量2018-2029、地域別現状・将来分析
・MRSA薬剤の種類別セグメント：経口、非経口
・MRSA薬剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・MRSA薬剤の用途別セグメント：病院薬局、小売薬局、電子薬局
・MRSA薬剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のMRSA薬剤市場
・企業別のグローバルMRSA薬剤市場データ：2018-2023年の年間販売量、市場シェア
・企業別のMRSA薬剤の年間売上：2018-2023年の売上、市場シェア
・企業別のMRSA薬剤販売価格
・主要企業のMRSA薬剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

MRSA薬剤の地域別レビュー
・地域別のMRSA薬剤市場規模2018-2023：年間販売量、売上
・主要国別のMRSA薬剤市場規模2018-2023：年間販売量、売上
・南北アメリカのMRSA薬剤販売の成長
・アジア太平洋のMRSA薬剤販売の成長
・ヨーロッパのMRSA薬剤販売の成長
・中東・アフリカのMRSA薬剤販売の成長

南北アメリカ市場
・南北アメリカの国別のMRSA薬剤販売量、売上（2018-2023）
・南北アメリカのMRSA薬剤の種類別販売量
・南北アメリカのMRSA薬剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のMRSA薬剤販売量、売上（2018-2023）
・アジア太平洋のMRSA薬剤の種類別販売量
・アジア太平洋のMRSA薬剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のMRSA薬剤販売量、売上（2018-2023）
・ヨーロッパのMRSA薬剤の種類別販売量
・ヨーロッパのMRSA薬剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のMRSA薬剤販売量、売上（2018-2023）
・中東・アフリカのMRSA薬剤の種類別販売量
・中東・アフリカのMRSA薬剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・MRSA薬剤の製造コスト構造分析
・MRSA薬剤の製造プロセス分析
・MRSA薬剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・MRSA薬剤の主要なグローバル販売業者
・MRSA薬剤の主要なグローバル顧客

地域別のMRSA薬剤市場予測レビュー
・地域別のMRSA薬剤市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・MRSA薬剤の種類別市場規模予測
・MRSA薬剤の用途別市場規模予測

主要企業分析
Allergan、 Merck、 Pfizer、 Theravance Biopharma、 Absynth Biologics、 Cumberland Pharmaceuticals、 AstraZeneca、 Basilea Pharmaceuticals、 Baxter、 Melinta Therapeutics
・企業情報
・MRSA薬剤製品
・MRSA薬剤販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global MRSA Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for MRSA Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for MRSA Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for MRSA Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key MRSA Drugs players cover Allergan, Merck, Pfizer, Theravance Biopharma, Absynth Biologics, Cumberland Pharmaceuticals, AstraZeneca, Basilea Pharmaceuticals and Baxter, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “MRSA Drugs Industry Forecast” looks at past sales and reviews total world MRSA Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected MRSA Drugs sales for 2023 through 2029. With MRSA Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world MRSA Drugs industry.
This Insight Report provides a comprehensive analysis of the global MRSA Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on MRSA Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global MRSA Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for MRSA Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global MRSA Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of MRSA Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Oral
Parenteral
Segmentation by application
Hospital Pharmacy
Retail Pharmacy
E-pharmacy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Allergan
Merck
Pfizer
Theravance Biopharma
Absynth Biologics
Cumberland Pharmaceuticals
AstraZeneca
Basilea Pharmaceuticals
Baxter
Melinta Therapeutics
Key Questions Addressed in this Report
What is the 10-year outlook for the global MRSA Drugs market?
What factors are driving MRSA Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do MRSA Drugs market opportunities vary by end market size?
How does MRSA Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global MRSA Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for MRSA Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for MRSA Drugs by Country/Region, 2018, 2022 & 2029
2.2 MRSA Drugs Segment by Type
2.2.1 Oral
2.2.2 Parenteral
2.3 MRSA Drugs Sales by Type
2.3.1 Global MRSA Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global MRSA Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global MRSA Drugs Sale Price by Type (2018-2023)
2.4 MRSA Drugs Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 E-pharmacy
2.5 MRSA Drugs Sales by Application
2.5.1 Global MRSA Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global MRSA Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global MRSA Drugs Sale Price by Application (2018-2023)
3 Global MRSA Drugs by Company
3.1 Global MRSA Drugs Breakdown Data by Company
3.1.1 Global MRSA Drugs Annual Sales by Company (2018-2023)
3.1.2 Global MRSA Drugs Sales Market Share by Company (2018-2023)
3.2 Global MRSA Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global MRSA Drugs Revenue by Company (2018-2023)
3.2.2 Global MRSA Drugs Revenue Market Share by Company (2018-2023)
3.3 Global MRSA Drugs Sale Price by Company
3.4 Key Manufacturers MRSA Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers MRSA Drugs Product Location Distribution
3.4.2 Players MRSA Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for MRSA Drugs by Geographic Region
4.1 World Historic MRSA Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global MRSA Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global MRSA Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic MRSA Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global MRSA Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global MRSA Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas MRSA Drugs Sales Growth
4.4 APAC MRSA Drugs Sales Growth
4.5 Europe MRSA Drugs Sales Growth
4.6 Middle East & Africa MRSA Drugs Sales Growth
5 Americas
5.1 Americas MRSA Drugs Sales by Country
5.1.1 Americas MRSA Drugs Sales by Country (2018-2023)
5.1.2 Americas MRSA Drugs Revenue by Country (2018-2023)
5.2 Americas MRSA Drugs Sales by Type
5.3 Americas MRSA Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC MRSA Drugs Sales by Region
6.1.1 APAC MRSA Drugs Sales by Region (2018-2023)
6.1.2 APAC MRSA Drugs Revenue by Region (2018-2023)
6.2 APAC MRSA Drugs Sales by Type
6.3 APAC MRSA Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe MRSA Drugs by Country
7.1.1 Europe MRSA Drugs Sales by Country (2018-2023)
7.1.2 Europe MRSA Drugs Revenue by Country (2018-2023)
7.2 Europe MRSA Drugs Sales by Type
7.3 Europe MRSA Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa MRSA Drugs by Country
8.1.1 Middle East & Africa MRSA Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa MRSA Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa MRSA Drugs Sales by Type
8.3 Middle East & Africa MRSA Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of MRSA Drugs
10.3 Manufacturing Process Analysis of MRSA Drugs
10.4 Industry Chain Structure of MRSA Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 MRSA Drugs Distributors
11.3 MRSA Drugs Customer
12 World Forecast Review for MRSA Drugs by Geographic Region
12.1 Global MRSA Drugs Market Size Forecast by Region
12.1.1 Global MRSA Drugs Forecast by Region (2024-2029)
12.1.2 Global MRSA Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global MRSA Drugs Forecast by Type
12.7 Global MRSA Drugs Forecast by Application
13 Key Players Analysis
13.1 Allergan
13.1.1 Allergan Company Information
13.1.2 Allergan MRSA Drugs Product Portfolios and Specifications
13.1.3 Allergan MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Allergan Main Business Overview
13.1.5 Allergan Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck MRSA Drugs Product Portfolios and Specifications
13.2.3 Merck MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer MRSA Drugs Product Portfolios and Specifications
13.3.3 Pfizer MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Theravance Biopharma
13.4.1 Theravance Biopharma Company Information
13.4.2 Theravance Biopharma MRSA Drugs Product Portfolios and Specifications
13.4.3 Theravance Biopharma MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Theravance Biopharma Main Business Overview
13.4.5 Theravance Biopharma Latest Developments
13.5 Absynth Biologics
13.5.1 Absynth Biologics Company Information
13.5.2 Absynth Biologics MRSA Drugs Product Portfolios and Specifications
13.5.3 Absynth Biologics MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Absynth Biologics Main Business Overview
13.5.5 Absynth Biologics Latest Developments
13.6 Cumberland Pharmaceuticals
13.6.1 Cumberland Pharmaceuticals Company Information
13.6.2 Cumberland Pharmaceuticals MRSA Drugs Product Portfolios and Specifications
13.6.3 Cumberland Pharmaceuticals MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Cumberland Pharmaceuticals Main Business Overview
13.6.5 Cumberland Pharmaceuticals Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca MRSA Drugs Product Portfolios and Specifications
13.7.3 AstraZeneca MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 Basilea Pharmaceuticals
13.8.1 Basilea Pharmaceuticals Company Information
13.8.2 Basilea Pharmaceuticals MRSA Drugs Product Portfolios and Specifications
13.8.3 Basilea Pharmaceuticals MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Basilea Pharmaceuticals Main Business Overview
13.8.5 Basilea Pharmaceuticals Latest Developments
13.9 Baxter
13.9.1 Baxter Company Information
13.9.2 Baxter MRSA Drugs Product Portfolios and Specifications
13.9.3 Baxter MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Baxter Main Business Overview
13.9.5 Baxter Latest Developments
13.10 Melinta Therapeutics
13.10.1 Melinta Therapeutics Company Information
13.10.2 Melinta Therapeutics MRSA Drugs Product Portfolios and Specifications
13.10.3 Melinta Therapeutics MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Melinta Therapeutics Main Business Overview
13.10.5 Melinta Therapeutics Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. MRSA Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. MRSA Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Parenteral
Table 5. Global MRSA Drugs Sales by Type (2018-2023) & (Tons)
Table 6. Global MRSA Drugs Sales Market Share by Type (2018-2023)
Table 7. Global MRSA Drugs Revenue by Type (2018-2023) & ($ million)
Table 8. Global MRSA Drugs Revenue Market Share by Type (2018-2023)
Table 9. Global MRSA Drugs Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global MRSA Drugs Sales by Application (2018-2023) & (Tons)
Table 11. Global MRSA Drugs Sales Market Share by Application (2018-2023)
Table 12. Global MRSA Drugs Revenue by Application (2018-2023)
Table 13. Global MRSA Drugs Revenue Market Share by Application (2018-2023)
Table 14. Global MRSA Drugs Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global MRSA Drugs Sales by Company (2018-2023) & (Tons)
Table 16. Global MRSA Drugs Sales Market Share by Company (2018-2023)
Table 17. Global MRSA Drugs Revenue by Company (2018-2023) ($ Millions)
Table 18. Global MRSA Drugs Revenue Market Share by Company (2018-2023)
Table 19. Global MRSA Drugs Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers MRSA Drugs Producing Area Distribution and Sales Area
Table 21. Players MRSA Drugs Products Offered
Table 22. MRSA Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global MRSA Drugs Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global MRSA Drugs Sales Market Share Geographic Region (2018-2023)
Table 27. Global MRSA Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global MRSA Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global MRSA Drugs Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global MRSA Drugs Sales Market Share by Country/Region (2018-2023)
Table 31. Global MRSA Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global MRSA Drugs Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas MRSA Drugs Sales by Country (2018-2023) & (Tons)
Table 34. Americas MRSA Drugs Sales Market Share by Country (2018-2023)
Table 35. Americas MRSA Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas MRSA Drugs Revenue Market Share by Country (2018-2023)
Table 37. Americas MRSA Drugs Sales by Type (2018-2023) & (Tons)
Table 38. Americas MRSA Drugs Sales by Application (2018-2023) & (Tons)
Table 39. APAC MRSA Drugs Sales by Region (2018-2023) & (Tons)
Table 40. APAC MRSA Drugs Sales Market Share by Region (2018-2023)
Table 41. APAC MRSA Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC MRSA Drugs Revenue Market Share by Region (2018-2023)
Table 43. APAC MRSA Drugs Sales by Type (2018-2023) & (Tons)
Table 44. APAC MRSA Drugs Sales by Application (2018-2023) & (Tons)
Table 45. Europe MRSA Drugs Sales by Country (2018-2023) & (Tons)
Table 46. Europe MRSA Drugs Sales Market Share by Country (2018-2023)
Table 47. Europe MRSA Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe MRSA Drugs Revenue Market Share by Country (2018-2023)
Table 49. Europe MRSA Drugs Sales by Type (2018-2023) & (Tons)
Table 50. Europe MRSA Drugs Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa MRSA Drugs Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa MRSA Drugs Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa MRSA Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa MRSA Drugs Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa MRSA Drugs Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa MRSA Drugs Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of MRSA Drugs
Table 58. Key Market Challenges & Risks of MRSA Drugs
Table 59. Key Industry Trends of MRSA Drugs
Table 60. MRSA Drugs Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. MRSA Drugs Distributors List
Table 63. MRSA Drugs Customer List
Table 64. Global MRSA Drugs Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global MRSA Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas MRSA Drugs Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas MRSA Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC MRSA Drugs Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC MRSA Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe MRSA Drugs Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe MRSA Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa MRSA Drugs Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa MRSA Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global MRSA Drugs Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global MRSA Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global MRSA Drugs Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global MRSA Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Allergan Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Allergan MRSA Drugs Product Portfolios and Specifications
Table 80. Allergan MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Allergan Main Business
Table 82. Allergan Latest Developments
Table 83. Merck Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck MRSA Drugs Product Portfolios and Specifications
Table 85. Merck MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Pfizer Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer MRSA Drugs Product Portfolios and Specifications
Table 90. Pfizer MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. Theravance Biopharma Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Theravance Biopharma MRSA Drugs Product Portfolios and Specifications
Table 95. Theravance Biopharma MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Theravance Biopharma Main Business
Table 97. Theravance Biopharma Latest Developments
Table 98. Absynth Biologics Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Absynth Biologics MRSA Drugs Product Portfolios and Specifications
Table 100. Absynth Biologics MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Absynth Biologics Main Business
Table 102. Absynth Biologics Latest Developments
Table 103. Cumberland Pharmaceuticals Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Cumberland Pharmaceuticals MRSA Drugs Product Portfolios and Specifications
Table 105. Cumberland Pharmaceuticals MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Cumberland Pharmaceuticals Main Business
Table 107. Cumberland Pharmaceuticals Latest Developments
Table 108. AstraZeneca Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. AstraZeneca MRSA Drugs Product Portfolios and Specifications
Table 110. AstraZeneca MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. AstraZeneca Main Business
Table 112. AstraZeneca Latest Developments
Table 113. Basilea Pharmaceuticals Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Basilea Pharmaceuticals MRSA Drugs Product Portfolios and Specifications
Table 115. Basilea Pharmaceuticals MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Basilea Pharmaceuticals Main Business
Table 117. Basilea Pharmaceuticals Latest Developments
Table 118. Baxter Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Baxter MRSA Drugs Product Portfolios and Specifications
Table 120. Baxter MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Baxter Main Business
Table 122. Baxter Latest Developments
Table 123. Melinta Therapeutics Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Melinta Therapeutics MRSA Drugs Product Portfolios and Specifications
Table 125. Melinta Therapeutics MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Melinta Therapeutics Main Business
Table 127. Melinta Therapeutics Latest Developments
List of Figures
Figure 1. Picture of MRSA Drugs
Figure 2. MRSA Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global MRSA Drugs Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global MRSA Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. MRSA Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Parenteral
Figure 11. Global MRSA Drugs Sales Market Share by Type in 2022
Figure 12. Global MRSA Drugs Revenue Market Share by Type (2018-2023)
Figure 13. MRSA Drugs Consumed in Hospital Pharmacy
Figure 14. Global MRSA Drugs Market: Hospital Pharmacy (2018-2023) & (Tons)
Figure 15. MRSA Drugs Consumed in Retail Pharmacy
Figure 16. Global MRSA Drugs Market: Retail Pharmacy (2018-2023) & (Tons)
Figure 17. MRSA Drugs Consumed in E-pharmacy
Figure 18. Global MRSA Drugs Market: E-pharmacy (2018-2023) & (Tons)
Figure 19. Global MRSA Drugs Sales Market Share by Application (2022)
Figure 20. Global MRSA Drugs Revenue Market Share by Application in 2022
Figure 21. MRSA Drugs Sales Market by Company in 2022 (Tons)
Figure 22. Global MRSA Drugs Sales Market Share by Company in 2022
Figure 23. MRSA Drugs Revenue Market by Company in 2022 ($ Million)
Figure 24. Global MRSA Drugs Revenue Market Share by Company in 2022
Figure 25. Global MRSA Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global MRSA Drugs Revenue Market Share by Geographic Region in 2022
Figure 27. Americas MRSA Drugs Sales 2018-2023 (Tons)
Figure 28. Americas MRSA Drugs Revenue 2018-2023 ($ Millions)
Figure 29. APAC MRSA Drugs Sales 2018-2023 (Tons)
Figure 30. APAC MRSA Drugs Revenue 2018-2023 ($ Millions)
Figure 31. Europe MRSA Drugs Sales 2018-2023 (Tons)
Figure 32. Europe MRSA Drugs Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa MRSA Drugs Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa MRSA Drugs Revenue 2018-2023 ($ Millions)
Figure 35. Americas MRSA Drugs Sales Market Share by Country in 2022
Figure 36. Americas MRSA Drugs Revenue Market Share by Country in 2022
Figure 37. Americas MRSA Drugs Sales Market Share by Type (2018-2023)
Figure 38. Americas MRSA Drugs Sales Market Share by Application (2018-2023)
Figure 39. United States MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC MRSA Drugs Sales Market Share by Region in 2022
Figure 44. APAC MRSA Drugs Revenue Market Share by Regions in 2022
Figure 45. APAC MRSA Drugs Sales Market Share by Type (2018-2023)
Figure 46. APAC MRSA Drugs Sales Market Share by Application (2018-2023)
Figure 47. China MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. India MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe MRSA Drugs Sales Market Share by Country in 2022
Figure 55. Europe MRSA Drugs Revenue Market Share by Country in 2022
Figure 56. Europe MRSA Drugs Sales Market Share by Type (2018-2023)
Figure 57. Europe MRSA Drugs Sales Market Share by Application (2018-2023)
Figure 58. Germany MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. France MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa MRSA Drugs Sales Market Share by Country in 2022
Figure 64. Middle East & Africa MRSA Drugs Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa MRSA Drugs Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa MRSA Drugs Sales Market Share by Application (2018-2023)
Figure 67. Egypt MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of MRSA Drugs in 2022
Figure 73. Manufacturing Process Analysis of MRSA Drugs
Figure 74. Industry Chain Structure of MRSA Drugs
Figure 75. Channels of Distribution
Figure 76. Global MRSA Drugs Sales Market Forecast by Region (2024-2029)
Figure 77. Global MRSA Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global MRSA Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global MRSA Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global MRSA Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global MRSA Drugs Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のMRSA薬剤市場予測 2023年-2029年] (コード：LP23DC00912)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のMRSA薬剤市場予測 2023年-2029年]についてメールでお問い合わせ
カテゴリー： 世界, 部品/材料, LP Information

世界のMRSA薬剤市場予測 2023年-2029年

【英語タイトル】Global MRSA Drugs Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC00912）・商品コード：LP23DC00912
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：108
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のMRSA薬剤市場」は、過去の販売実績から2022年の世界のMRSA薬剤の総販売量を検討し、2023年から2029年の予測されるMRSA薬剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のMRSA薬剤の市場規模を掲載し、XXX百万米ドル規模の世界のMRSA薬剤市場の詳細な分析を提供します。本インサイトレポートは、世界のMRSA薬剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のMRSA薬剤市場における各社の独自のポジションをより深く理解するために、MRSA薬剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のMRSA薬剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。MRSA薬剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。MRSA薬剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。MRSA薬剤のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

MRSA薬剤の世界主要メーカーとしては、Allergan、 Merck、 Pfizer、 Theravance Biopharma、 Absynth Biologics、 Cumberland Pharmaceuticals、 AstraZeneca、 Basilea Pharmaceuticals、 Baxter、 Melinta Therapeuticsなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のMRSA薬剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではMRSA薬剤市場をセグメンテーションし、種類別 (経口、非経口)、用途別 (病院薬局、小売薬局、電子薬局)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：経口、非経口

・用途別区分：病院薬局、小売薬局、電子薬局

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のMRSA薬剤市場の10年間の市場状況・展望は？
・世界および地域別に見たMRSA薬剤市場成長の要因は何か？
・MRSA薬剤の市場機会はエンドマーケットの規模によってどのように変化するのか？
・MRSA薬剤のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：MRSA薬剤の年間販売量2018-2029、地域別現状・将来分析
・MRSA薬剤の種類別セグメント：経口、非経口
・MRSA薬剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・MRSA薬剤の用途別セグメント：病院薬局、小売薬局、電子薬局
・MRSA薬剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のMRSA薬剤市場
・企業別のグローバルMRSA薬剤市場データ：2018-2023年の年間販売量、市場シェア
・企業別のMRSA薬剤の年間売上：2018-2023年の売上、市場シェア
・企業別のMRSA薬剤販売価格
・主要企業のMRSA薬剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

MRSA薬剤の地域別レビュー
・地域別のMRSA薬剤市場規模2018-2023：年間販売量、売上
・主要国別のMRSA薬剤市場規模2018-2023：年間販売量、売上
・南北アメリカのMRSA薬剤販売の成長
・アジア太平洋のMRSA薬剤販売の成長
・ヨーロッパのMRSA薬剤販売の成長
・中東・アフリカのMRSA薬剤販売の成長

南北アメリカ市場
・南北アメリカの国別のMRSA薬剤販売量、売上（2018-2023）
・南北アメリカのMRSA薬剤の種類別販売量
・南北アメリカのMRSA薬剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のMRSA薬剤販売量、売上（2018-2023）
・アジア太平洋のMRSA薬剤の種類別販売量
・アジア太平洋のMRSA薬剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のMRSA薬剤販売量、売上（2018-2023）
・ヨーロッパのMRSA薬剤の種類別販売量
・ヨーロッパのMRSA薬剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のMRSA薬剤販売量、売上（2018-2023）
・中東・アフリカのMRSA薬剤の種類別販売量
・中東・アフリカのMRSA薬剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・MRSA薬剤の製造コスト構造分析
・MRSA薬剤の製造プロセス分析
・MRSA薬剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・MRSA薬剤の主要なグローバル販売業者
・MRSA薬剤の主要なグローバル顧客

地域別のMRSA薬剤市場予測レビュー
・地域別のMRSA薬剤市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・MRSA薬剤の種類別市場規模予測
・MRSA薬剤の用途別市場規模予測

主要企業分析
Allergan、 Merck、 Pfizer、 Theravance Biopharma、 Absynth Biologics、 Cumberland Pharmaceuticals、 AstraZeneca、 Basilea Pharmaceuticals、 Baxter、 Melinta Therapeutics
・企業情報
・MRSA薬剤製品
・MRSA薬剤販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global MRSA Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for MRSA Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for MRSA Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for MRSA Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key MRSA Drugs players cover Allergan, Merck, Pfizer, Theravance Biopharma, Absynth Biologics, Cumberland Pharmaceuticals, AstraZeneca, Basilea Pharmaceuticals and Baxter, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “MRSA Drugs Industry Forecast” looks at past sales and reviews total world MRSA Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected MRSA Drugs sales for 2023 through 2029. With MRSA Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world MRSA Drugs industry.
This Insight Report provides a comprehensive analysis of the global MRSA Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on MRSA Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global MRSA Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for MRSA Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global MRSA Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of MRSA Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Oral
Parenteral
Segmentation by application
Hospital Pharmacy
Retail Pharmacy
E-pharmacy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Allergan
Merck
Pfizer
Theravance Biopharma
Absynth Biologics
Cumberland Pharmaceuticals
AstraZeneca
Basilea Pharmaceuticals
Baxter
Melinta Therapeutics
Key Questions Addressed in this Report
What is the 10-year outlook for the global MRSA Drugs market?
What factors are driving MRSA Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do MRSA Drugs market opportunities vary by end market size?
How does MRSA Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global MRSA Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for MRSA Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for MRSA Drugs by Country/Region, 2018, 2022 & 2029
2.2 MRSA Drugs Segment by Type
2.2.1 Oral
2.2.2 Parenteral
2.3 MRSA Drugs Sales by Type
2.3.1 Global MRSA Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global MRSA Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global MRSA Drugs Sale Price by Type (2018-2023)
2.4 MRSA Drugs Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 E-pharmacy
2.5 MRSA Drugs Sales by Application
2.5.1 Global MRSA Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global MRSA Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global MRSA Drugs Sale Price by Application (2018-2023)
3 Global MRSA Drugs by Company
3.1 Global MRSA Drugs Breakdown Data by Company
3.1.1 Global MRSA Drugs Annual Sales by Company (2018-2023)
3.1.2 Global MRSA Drugs Sales Market Share by Company (2018-2023)
3.2 Global MRSA Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global MRSA Drugs Revenue by Company (2018-2023)
3.2.2 Global MRSA Drugs Revenue Market Share by Company (2018-2023)
3.3 Global MRSA Drugs Sale Price by Company
3.4 Key Manufacturers MRSA Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers MRSA Drugs Product Location Distribution
3.4.2 Players MRSA Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for MRSA Drugs by Geographic Region
4.1 World Historic MRSA Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global MRSA Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global MRSA Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic MRSA Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global MRSA Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global MRSA Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas MRSA Drugs Sales Growth
4.4 APAC MRSA Drugs Sales Growth
4.5 Europe MRSA Drugs Sales Growth
4.6 Middle East & Africa MRSA Drugs Sales Growth
5 Americas
5.1 Americas MRSA Drugs Sales by Country
5.1.1 Americas MRSA Drugs Sales by Country (2018-2023)
5.1.2 Americas MRSA Drugs Revenue by Country (2018-2023)
5.2 Americas MRSA Drugs Sales by Type
5.3 Americas MRSA Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC MRSA Drugs Sales by Region
6.1.1 APAC MRSA Drugs Sales by Region (2018-2023)
6.1.2 APAC MRSA Drugs Revenue by Region (2018-2023)
6.2 APAC MRSA Drugs Sales by Type
6.3 APAC MRSA Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe MRSA Drugs by Country
7.1.1 Europe MRSA Drugs Sales by Country (2018-2023)
7.1.2 Europe MRSA Drugs Revenue by Country (2018-2023)
7.2 Europe MRSA Drugs Sales by Type
7.3 Europe MRSA Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa MRSA Drugs by Country
8.1.1 Middle East & Africa MRSA Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa MRSA Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa MRSA Drugs Sales by Type
8.3 Middle East & Africa MRSA Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of MRSA Drugs
10.3 Manufacturing Process Analysis of MRSA Drugs
10.4 Industry Chain Structure of MRSA Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 MRSA Drugs Distributors
11.3 MRSA Drugs Customer
12 World Forecast Review for MRSA Drugs by Geographic Region
12.1 Global MRSA Drugs Market Size Forecast by Region
12.1.1 Global MRSA Drugs Forecast by Region (2024-2029)
12.1.2 Global MRSA Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global MRSA Drugs Forecast by Type
12.7 Global MRSA Drugs Forecast by Application
13 Key Players Analysis
13.1 Allergan
13.1.1 Allergan Company Information
13.1.2 Allergan MRSA Drugs Product Portfolios and Specifications
13.1.3 Allergan MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Allergan Main Business Overview
13.1.5 Allergan Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck MRSA Drugs Product Portfolios and Specifications
13.2.3 Merck MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer MRSA Drugs Product Portfolios and Specifications
13.3.3 Pfizer MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Theravance Biopharma
13.4.1 Theravance Biopharma Company Information
13.4.2 Theravance Biopharma MRSA Drugs Product Portfolios and Specifications
13.4.3 Theravance Biopharma MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Theravance Biopharma Main Business Overview
13.4.5 Theravance Biopharma Latest Developments
13.5 Absynth Biologics
13.5.1 Absynth Biologics Company Information
13.5.2 Absynth Biologics MRSA Drugs Product Portfolios and Specifications
13.5.3 Absynth Biologics MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Absynth Biologics Main Business Overview
13.5.5 Absynth Biologics Latest Developments
13.6 Cumberland Pharmaceuticals
13.6.1 Cumberland Pharmaceuticals Company Information
13.6.2 Cumberland Pharmaceuticals MRSA Drugs Product Portfolios and Specifications
13.6.3 Cumberland Pharmaceuticals MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Cumberland Pharmaceuticals Main Business Overview
13.6.5 Cumberland Pharmaceuticals Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca MRSA Drugs Product Portfolios and Specifications
13.7.3 AstraZeneca MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 Basilea Pharmaceuticals
13.8.1 Basilea Pharmaceuticals Company Information
13.8.2 Basilea Pharmaceuticals MRSA Drugs Product Portfolios and Specifications
13.8.3 Basilea Pharmaceuticals MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Basilea Pharmaceuticals Main Business Overview
13.8.5 Basilea Pharmaceuticals Latest Developments
13.9 Baxter
13.9.1 Baxter Company Information
13.9.2 Baxter MRSA Drugs Product Portfolios and Specifications
13.9.3 Baxter MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Baxter Main Business Overview
13.9.5 Baxter Latest Developments
13.10 Melinta Therapeutics
13.10.1 Melinta Therapeutics Company Information
13.10.2 Melinta Therapeutics MRSA Drugs Product Portfolios and Specifications
13.10.3 Melinta Therapeutics MRSA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Melinta Therapeutics Main Business Overview
13.10.5 Melinta Therapeutics Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. MRSA Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. MRSA Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Parenteral
Table 5. Global MRSA Drugs Sales by Type (2018-2023) & (Tons)
Table 6. Global MRSA Drugs Sales Market Share by Type (2018-2023)
Table 7. Global MRSA Drugs Revenue by Type (2018-2023) & ($ million)
Table 8. Global MRSA Drugs Revenue Market Share by Type (2018-2023)
Table 9. Global MRSA Drugs Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global MRSA Drugs Sales by Application (2018-2023) & (Tons)
Table 11. Global MRSA Drugs Sales Market Share by Application (2018-2023)
Table 12. Global MRSA Drugs Revenue by Application (2018-2023)
Table 13. Global MRSA Drugs Revenue Market Share by Application (2018-2023)
Table 14. Global MRSA Drugs Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global MRSA Drugs Sales by Company (2018-2023) & (Tons)
Table 16. Global MRSA Drugs Sales Market Share by Company (2018-2023)
Table 17. Global MRSA Drugs Revenue by Company (2018-2023) ($ Millions)
Table 18. Global MRSA Drugs Revenue Market Share by Company (2018-2023)
Table 19. Global MRSA Drugs Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers MRSA Drugs Producing Area Distribution and Sales Area
Table 21. Players MRSA Drugs Products Offered
Table 22. MRSA Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global MRSA Drugs Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global MRSA Drugs Sales Market Share Geographic Region (2018-2023)
Table 27. Global MRSA Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global MRSA Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global MRSA Drugs Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global MRSA Drugs Sales Market Share by Country/Region (2018-2023)
Table 31. Global MRSA Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global MRSA Drugs Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas MRSA Drugs Sales by Country (2018-2023) & (Tons)
Table 34. Americas MRSA Drugs Sales Market Share by Country (2018-2023)
Table 35. Americas MRSA Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas MRSA Drugs Revenue Market Share by Country (2018-2023)
Table 37. Americas MRSA Drugs Sales by Type (2018-2023) & (Tons)
Table 38. Americas MRSA Drugs Sales by Application (2018-2023) & (Tons)
Table 39. APAC MRSA Drugs Sales by Region (2018-2023) & (Tons)
Table 40. APAC MRSA Drugs Sales Market Share by Region (2018-2023)
Table 41. APAC MRSA Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC MRSA Drugs Revenue Market Share by Region (2018-2023)
Table 43. APAC MRSA Drugs Sales by Type (2018-2023) & (Tons)
Table 44. APAC MRSA Drugs Sales by Application (2018-2023) & (Tons)
Table 45. Europe MRSA Drugs Sales by Country (2018-2023) & (Tons)
Table 46. Europe MRSA Drugs Sales Market Share by Country (2018-2023)
Table 47. Europe MRSA Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe MRSA Drugs Revenue Market Share by Country (2018-2023)
Table 49. Europe MRSA Drugs Sales by Type (2018-2023) & (Tons)
Table 50. Europe MRSA Drugs Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa MRSA Drugs Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa MRSA Drugs Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa MRSA Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa MRSA Drugs Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa MRSA Drugs Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa MRSA Drugs Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of MRSA Drugs
Table 58. Key Market Challenges & Risks of MRSA Drugs
Table 59. Key Industry Trends of MRSA Drugs
Table 60. MRSA Drugs Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. MRSA Drugs Distributors List
Table 63. MRSA Drugs Customer List
Table 64. Global MRSA Drugs Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global MRSA Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas MRSA Drugs Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas MRSA Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC MRSA Drugs Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC MRSA Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe MRSA Drugs Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe MRSA Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa MRSA Drugs Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa MRSA Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global MRSA Drugs Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global MRSA Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global MRSA Drugs Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global MRSA Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Allergan Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Allergan MRSA Drugs Product Portfolios and Specifications
Table 80. Allergan MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Allergan Main Business
Table 82. Allergan Latest Developments
Table 83. Merck Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck MRSA Drugs Product Portfolios and Specifications
Table 85. Merck MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Pfizer Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer MRSA Drugs Product Portfolios and Specifications
Table 90. Pfizer MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. Theravance Biopharma Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Theravance Biopharma MRSA Drugs Product Portfolios and Specifications
Table 95. Theravance Biopharma MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Theravance Biopharma Main Business
Table 97. Theravance Biopharma Latest Developments
Table 98. Absynth Biologics Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Absynth Biologics MRSA Drugs Product Portfolios and Specifications
Table 100. Absynth Biologics MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Absynth Biologics Main Business
Table 102. Absynth Biologics Latest Developments
Table 103. Cumberland Pharmaceuticals Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Cumberland Pharmaceuticals MRSA Drugs Product Portfolios and Specifications
Table 105. Cumberland Pharmaceuticals MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Cumberland Pharmaceuticals Main Business
Table 107. Cumberland Pharmaceuticals Latest Developments
Table 108. AstraZeneca Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. AstraZeneca MRSA Drugs Product Portfolios and Specifications
Table 110. AstraZeneca MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. AstraZeneca Main Business
Table 112. AstraZeneca Latest Developments
Table 113. Basilea Pharmaceuticals Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Basilea Pharmaceuticals MRSA Drugs Product Portfolios and Specifications
Table 115. Basilea Pharmaceuticals MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Basilea Pharmaceuticals Main Business
Table 117. Basilea Pharmaceuticals Latest Developments
Table 118. Baxter Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Baxter MRSA Drugs Product Portfolios and Specifications
Table 120. Baxter MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Baxter Main Business
Table 122. Baxter Latest Developments
Table 123. Melinta Therapeutics Basic Information, MRSA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Melinta Therapeutics MRSA Drugs Product Portfolios and Specifications
Table 125. Melinta Therapeutics MRSA Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Melinta Therapeutics Main Business
Table 127. Melinta Therapeutics Latest Developments
List of Figures
Figure 1. Picture of MRSA Drugs
Figure 2. MRSA Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global MRSA Drugs Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global MRSA Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. MRSA Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Parenteral
Figure 11. Global MRSA Drugs Sales Market Share by Type in 2022
Figure 12. Global MRSA Drugs Revenue Market Share by Type (2018-2023)
Figure 13. MRSA Drugs Consumed in Hospital Pharmacy
Figure 14. Global MRSA Drugs Market: Hospital Pharmacy (2018-2023) & (Tons)
Figure 15. MRSA Drugs Consumed in Retail Pharmacy
Figure 16. Global MRSA Drugs Market: Retail Pharmacy (2018-2023) & (Tons)
Figure 17. MRSA Drugs Consumed in E-pharmacy
Figure 18. Global MRSA Drugs Market: E-pharmacy (2018-2023) & (Tons)
Figure 19. Global MRSA Drugs Sales Market Share by Application (2022)
Figure 20. Global MRSA Drugs Revenue Market Share by Application in 2022
Figure 21. MRSA Drugs Sales Market by Company in 2022 (Tons)
Figure 22. Global MRSA Drugs Sales Market Share by Company in 2022
Figure 23. MRSA Drugs Revenue Market by Company in 2022 ($ Million)
Figure 24. Global MRSA Drugs Revenue Market Share by Company in 2022
Figure 25. Global MRSA Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global MRSA Drugs Revenue Market Share by Geographic Region in 2022
Figure 27. Americas MRSA Drugs Sales 2018-2023 (Tons)
Figure 28. Americas MRSA Drugs Revenue 2018-2023 ($ Millions)
Figure 29. APAC MRSA Drugs Sales 2018-2023 (Tons)
Figure 30. APAC MRSA Drugs Revenue 2018-2023 ($ Millions)
Figure 31. Europe MRSA Drugs Sales 2018-2023 (Tons)
Figure 32. Europe MRSA Drugs Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa MRSA Drugs Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa MRSA Drugs Revenue 2018-2023 ($ Millions)
Figure 35. Americas MRSA Drugs Sales Market Share by Country in 2022
Figure 36. Americas MRSA Drugs Revenue Market Share by Country in 2022
Figure 37. Americas MRSA Drugs Sales Market Share by Type (2018-2023)
Figure 38. Americas MRSA Drugs Sales Market Share by Application (2018-2023)
Figure 39. United States MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC MRSA Drugs Sales Market Share by Region in 2022
Figure 44. APAC MRSA Drugs Revenue Market Share by Regions in 2022
Figure 45. APAC MRSA Drugs Sales Market Share by Type (2018-2023)
Figure 46. APAC MRSA Drugs Sales Market Share by Application (2018-2023)
Figure 47. China MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. India MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe MRSA Drugs Sales Market Share by Country in 2022
Figure 55. Europe MRSA Drugs Revenue Market Share by Country in 2022
Figure 56. Europe MRSA Drugs Sales Market Share by Type (2018-2023)
Figure 57. Europe MRSA Drugs Sales Market Share by Application (2018-2023)
Figure 58. Germany MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. France MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa MRSA Drugs Sales Market Share by Country in 2022
Figure 64. Middle East & Africa MRSA Drugs Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa MRSA Drugs Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa MRSA Drugs Sales Market Share by Application (2018-2023)
Figure 67. Egypt MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country MRSA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of MRSA Drugs in 2022
Figure 73. Manufacturing Process Analysis of MRSA Drugs
Figure 74. Industry Chain Structure of MRSA Drugs
Figure 75. Channels of Distribution
Figure 76. Global MRSA Drugs Sales Market Forecast by Region (2024-2029)
Figure 77. Global MRSA Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global MRSA Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global MRSA Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global MRSA Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global MRSA Drugs Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のMRSA薬剤市場予測 2023年-2029年] (コード：LP23DC00912)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のMRSA薬剤市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のMRSA薬剤市場予測 2023年-2029年
  • 世界のかゆみ止め薬市場予測 2023年-2029年
  • 世界の骨代謝治療薬市場予測 2023年-2029年
  • 世界の核放射線治療薬市場予測 2023年-2029年
  • 世界の酒石酸水素メタラミノールAPI市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆